Treatments for Bph.
Other than skin cancer, prostate cancer is the most common cancer in American men. The latest American Cancer Society estimates for prostate cancer in the United States are for 2009:
About 192, 280 new cases of prostate cancer will be diagnosed
27,360 men will die of prostate cancer.
About 1 man in 6 will be diagnosed with prostate cancer during his lifetime. More than 2 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today.
Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. About 1 man in 35 will die of prostate cancer. Prostate cancer accounts for about 10% of cancer-related deaths in men.
The 5-year survival rate refers to the percentage of patients who live at least 5 years after their cancer is diagnosed. These rates are used to create a standard way of discussing prognosis (outlook). Of course, many of these patients live much longer than 5 years after diagnosis. Five-year survival rates are based on patients diagnosed and first treated more than 5 years ago. Improvements in treatment since then may result in a better outlook for recently diagnosed patients. Five-year relative survival rates compare the observed survival with that expected for people without the cancer. That means that relative survival only talks about deaths from the cancer in question. This is a more accurate way to describe the outlook for patients with a certain cancer.
Learn more about prostate bph treatment now.